Peripheral neuropathy decisions — 2026

The Veteran's service connection for peripheral neuropathy of the right and left lower extremities is granted due to exposure to herbicide agents, specifically Agent Orange. The claim is based on a presumption of service connection.

The Veteran's claims for increased ratings and SMC based on peripheral neuropathy of the lower extremities and upper extremity have been granted. The effective date is set at February 10, 2022.

The Veteran's claims for service connection for peripheral neuropathy of the hands and feet, headaches, and sleep apnea were denied as there is no evidence of a current disability or a nexus to service.,No effective date earlier than August 11, 2023, was granted for the award of service connection for tinnitus.

The Veteran's service-connected conditions, including prostate cancer residuals, coronary artery disease (CAD), bilateral lower extremity diabetic peripheral neuropathy (neuropathy), and diabetes, prevent him from obtaining or maintaining substantially gainful employment. The Board has granted a total disability based on individual unemployability (TDIU).

The Board has remanded several claims for further development due to a duty-to-assist error, including obtaining private treatment records from the Veteran's nursing facility.

PTSD and Parkinson's disease with related secondary disabilities are not rated higher than the current ratings.,PN of the upper and lower extremities, bilateral hearing loss, and SMC are denied.

The Veteran's heart condition, left and right sciatic diabetic neuropathies are all granted as secondary to service-connected diabetes mellitus. The initial disability ratings for both conditions have been increased to 40 percent.

The Board has denied the Veteran's claim for service connection for bilateral foot neuropathy, finding that there is no evidence of a link between his current condition and his military service. The Board noted that the Veteran had complaints of toe trauma during boot camp but did not report numbness or pain in service. Post-service medical records show consistent treatment without complaints of nerve damage.

The Veteran's claim for SMC based on the need for regular aid and attendance of another person is granted due to his service-connected peripheral neuropathy and above-the-knee amputation.

The reduction of the fifth cranial nerve (trigeminal) neuropathy rating from 10 percent to noncompensable effective August 8, 2025 was improper. The Veteran's disability has been restored to a 10 percent rating.

The Board has granted service connection for right lower extremity and left lower extremity peripheral neuropathy, finding that the Veteran's symptoms are at least as likely as not related to his exposure to herbicide agents during active service.

The Veteran's service-connected COPD, coronary artery disease (CAD), and diabetes type II with lower-extremity peripheral neuropathy (PN) render him unemployable and require a need for regular aid and assistance such that he should be awarded a total disability rating due to individual unemployability (TDIU) and special monthly compensation (SMC) for aid and attendance (A&A).

The Veteran's claims for increased ratings for his service-connected peripheral neuropathy and radiculopathy conditions have been denied. The evidence does not support the assignment of higher ratings under the applicable rating criteria.

The Veteran's claims for service connection for myasthenia gravis, bilateral lower extremity peripheral neuropathy, and entitlement to a TDIU were denied.,An effective date of July 29, 2021, was granted for the award of service connection for myasthenia gravis.

The Veteran's claims for service connection for left upper extremity muscle cramps, right upper extremity muscle cramps, and groin abscesses have been granted with effective dates of February 22, 2018.,Prior to this date, the Veteran was not in receipt of a compensable disability rating for his left upper extremity muscle cramps and peripheral neuropathy.

The Board has decided to remand two claims for service connection for neuropathy of the left and right feet due to errors in obtaining relevant medical records and inadequate examination opinions. The Veteran's conditions are being reviewed again with additional evidence and a new VA examination.

The Veteran's service-connected disabilities, including bilateral upper and lower extremity diabetic peripheral neuropathy, have rendered him unable to secure and follow a substantially gainful occupation. The Board has granted the TDIU claim based on this finding.

The Board has determined that the decision on appeal was not legally adequate and requires remand for further action, including obtaining a medical opinion from the Centralized Eligibility and Appeals Team (CEAT) regarding the Veteran's eligibility for PCAFC benefits.

The Board has denied the Veteran's claim for a disability rating in excess of 20 percent for diabetes mellitus type II, finding that the evidence does not support the requirement of 'regulation of activities' as required by Diagnostic Code 7913.

The Board has determined that the Veteran does not have a current diagnosis of lower extremity peripheral neuropathy, and therefore service connection for this condition is denied. The remaining issues on appeal are remanded due to pre-decisional duty to assist errors.